Profile data is unavailable for this security.
About the company
Herborium Group, Inc. is a botanical therapeutics company focused on developing, licensing, and marketing of proprietary, botanical based medicinal products, targeting unmet medical needs. The Company responds to both consumers and healthcare professionals demand for treatment and prevention of selected diseases and health concerns. Its flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. It is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. AcnEase Skin Management System is a set of complementary all natural skin products which enhance the results of AcnEase. Its products include Natural Multi-tasking Acne Mask, Firming Collagen Peptide Serum, Accelerated Botanical Brightening Serum, Firming Collagen Peptide Serum, RETINOL RX, Mineral Sun Defense SPF 30, Vitamin C Antioxidant Serum and Glycolic Smoothing Serum.
- Revenue in USD (TTM)340.33k
- Net income in USD-318.65k
- Incorporated1996
- Employees2.00
- LocationHerborium Group Inc4306 Kenston placeMISSOURI CITY 77459United StatesUSA
- Phone+1 (201) 849-4431
- Fax+1 (866) 880-4817
- Websitehttps://www.herborium.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CeCors Inc | -100.00bn | -100.00bn | 826.55k | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
| PMGC Holdings Inc | 285.95k | -4.48m | 864.83k | 2.00 | -- | 0.0373 | -- | 3.02 | -57.57 | -129.01 | 3.93 | 45.64 | 0.0219 | 0.373 | 1.98 | 142,975.00 | -34.29 | -- | -48.32 | -- | 27.29 | -- | -1,567.42 | -- | 1.77 | -32.16 | 0.2734 | -- | -- | -- | -142.45 | -- | -- | -- |
| Lipella Pharmaceuticals Inc | 389.79k | -5.33m | 878.42k | 5.00 | -- | 0.5905 | -- | 2.25 | -2.41 | -2.41 | 0.1286 | 0.3219 | 0.1729 | -- | 25.08 | 77,958.00 | -236.36 | -101.93 | -336.65 | -125.09 | -- | -- | -1,367.34 | -592.18 | -- | -- | 0.00 | -- | 19.29 | -5.04 | -8.60 | -- | -- | -- |
| CERo Therapeutics Holdings Inc | 0.00 | -49.19m | 896.86k | 8.00 | -- | -- | -- | -- | -175.56 | -175.56 | 0.00 | -3.04 | 0.00 | -- | -- | 0.00 | -282.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.12 | -- | -- | -- |
| Protagenic Therapeutics Inc | -100.00bn | -100.00bn | 948.09k | 1.00 | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2945 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Emmaus Life Sciences Inc | 11.89m | -7.29m | 985.89k | 34.00 | -- | -- | -- | 0.0829 | -0.1141 | -0.1141 | 0.1862 | -0.9315 | 0.4945 | 0.6596 | 3.13 | 349,794.10 | -30.31 | -14.68 | -- | -211.99 | 92.17 | 90.14 | -61.29 | -32.65 | 0.0557 | -0.1912 | -- | -- | -43.73 | -6.05 | -72.86 | -- | -27.52 | -- |
| Herborium Group Inc | 340.33k | -318.65k | 1.09m | 2.00 | -- | -- | -- | 3.21 | -0.3492 | -0.3492 | 0.3672 | -1.16 | 2.32 | 3.89 | 25.94 | -- | -216.97 | -490.56 | -- | -- | 58.31 | 56.36 | -93.63 | -186.81 | 0.0331 | -39.14 | -- | -- | 19.45 | -18.15 | 120.44 | -- | -- | -- |
| Halberd Corp | 281.24k | 25.34k | 1.10m | 3.00 | 0.6681 | -- | 43.21 | 3.90 | 0.0023 | 0.0023 | 0.0018 | -0.0002 | 0.1449 | 0.0303 | 2.52 | -- | 1.31 | -- | 4.58 | -- | 50.00 | -- | 9.01 | -- | 0.2661 | 1.35 | 1.02 | -- | 271.52 | -- | -60.11 | -- | -- | -- |
| Aditxt Inc | 5.95k | -42.24m | 1.23m | 26.00 | -- | -- | -- | 206.56 | -13,234.74 | -13,234.74 | 0.3444 | -151.86 | 0.0003 | 1.54 | 0.0304 | 228.85 | -207.03 | -148.78 | -- | -279.11 | -1,134.96 | -- | -724,419.70 | -8,283.15 | 0.02 | -12.48 | -- | -- | -79.23 | -- | -23.40 | -- | -- | -- |
| International Stem Cell Corp | 9.39m | -149.00k | 1.32m | 32.00 | -- | -- | 8.20 | 0.1406 | -0.0187 | -0.0187 | 1.17 | 0.0655 | 1.80 | 2.66 | 11.08 | 293,468.80 | -1.13 | -16.11 | -10.84 | -52.88 | 57.86 | 59.53 | -0.6283 | -10.91 | 0.4604 | 0.6258 | 0.8632 | -- | 16.64 | -0.8308 | -59.54 | -- | -19.12 | -- |
| Ensysce Biosciences Inc | 4.49m | -10.97m | 1.45m | 7.00 | -- | 1.08 | -- | 0.3227 | -6.36 | -6.36 | 2.32 | 0.3783 | 0.7144 | -- | 5.02 | 641,138.60 | -174.67 | -48.70 | -270.43 | -62.66 | -- | -- | -244.49 | -501.34 | -- | -457.15 | 0.3071 | -- | 133.58 | -- | 24.83 | -- | -- | -- |
| Pharmagreen Biotech Inc | 3.01k | -226.26k | 1.46m | 0.00 | -- | -- | 2.64 | 485.06 | -0.0003 | -0.0003 | 0.00 | -0.0035 | 0.0286 | 0.2026 | 0.0669 | -- | -214.92 | -709.50 | -- | -- | 44.85 | -- | -7,518.27 | -147,637.60 | 0.0375 | -- | -- | -- | 13.67 | -- | -76.59 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Coston, McIsaac & Partners, Inc.as of 31 Dec 2025 | 1.00 | 0.00% |
